Hepatitis D: Thirty years after

Journal of Hepatology

Volumn 50, Issue 5, 2009, Pages 1043-1050

  Rizzetto, Mario ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Diagnosis; Epidemiology; Hepatitis D virus; Management; Virology

Indexed keywords

ADEFOVIR; ALPHA INTERFERON; ANTIVIRUS AGENT; FAMCICLOVIR; FTI 2153; LAMIVUDINE; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE METHYL ESTER; PEGINTERFERON ALPHA2B; UNCLASSIFIED DRUG;

ANTIVIRAL THERAPY; CHRONIC HEPATITIS; DELTA AGENT HEPATITIS; GENE STRUCTURE; GENETIC VARIABILITY; HEPATITIS DELTA VIRUS; HUMAN; LIVER BIOPSY; MONOTHERAPY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; VIRAL GENETICS; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; HEPATITIS B, CHRONIC; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; INTERFERONS; VIRUS REPLICATION;

EID: 64749114179     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.01.004     Document Type: Review

References (94)

1. Rizzetto M., Canese M.G., Aricò S., Crivelli O., Trepo C., Bonino F., et al. Immunofluorescence detection of a new antigen-antibody system (delta/anti-delta) associated with hepatitis B virus in liver and in serum of HBsAg carriers. Gut 18 (1977) 997-1003
2. Rizzetto M., Hoyer B., Canese M.G., Shih J.W.K., Purcell R.H., and Gerin J.L. Delta antigen: the association of delta antigen with hepatitis B surface antigen and ribonucleic acid in the serum of delta infected chimpanzees. Proc Natl Acad Sci New York 77 (1980) 6124-6128
3. Rizzetto M., Canese M.G., Gerin J.L., London W.T., Sly L.D., and Purcell R.H. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 141 (1980) 590-602
4. Rizzetto M., and Verme G. Delta hepatitis. J Hepatol 1 (1985) 187-193
5. Branch A.D., Benenfeld B.J., Baroudy B.M., Wells F.V., Gerin J.L., and Robertson H.D. An ultraviolet-sensitive RNA structural element in a viroid-like domain of the hepatitis delta virus. Science 243 (1989) 649-652
6. Ferré-D'Amaré A.R., Zhou K., and Doudna J.A. Crystal structure of a hepatitis delta virus ribozyme. Nature 395 (1998) 567-574
7. Been M.D. HDV ribozymes. Curr Top Microbiol Immunol 307 (2006) 47-65
8. Nakano S., Chadalavada D.M., and Bevilacqua P.C. General acid-base catalysis in the mechanism of a hepatitis delta virus. Science 287 (2000) 1493-1497
9. Tsagris E.M., Marti{dotless}́nez de Alba A.E., Gozmanova M., and Kalantidis K. Viroids. Cell Microbiol 10 (2008) 2168-2179
10. Salehi-Ashtiani K., Lupták A., Litovchick A., and Szostak J.W. A genome wide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene. Science 313 (2006) 1788-1792
11. Brazas R., and Ganem D. A cellular homolog of hepatitis delta antigen: implications for viral replication and evolution. Science 274 (1996) 90-94
12. Taylor J.M. Structure and replication of hepatitis delta virus RNA. Curr Top Microbiol Immunol 307 (2006) 1-23
13. Lai M.M. RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus. J Virol 79 (2005) 7951-7958
14. Fu T.B., and Taylor J. The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates. J Virol 67 (1993) 6965-6972
15. Kuo M.Y., Chao M., and Taylor J. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol 63 (1989) 1945-1950
16. Chang J., Sigal L.J., Lerro A., and Taylor J. Replication of the human hepatitis delta virus genome is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences. J Virol 75 (2001) 3469-3473
17. Liu Y.T., Brazas R., and Ganem D. Efficient hepatitis delta virus RNA replication in avian cells requires a permissive factor(s) from mammalian cells. J Virol 75 (2001) 7489-7493
18. Sureau C. The role of the HBV envelope proteins in the HDV replication cycle. Curr Top Microbiol Immunol 307 (2006) 113-131
19. Wang C.J., Chen P.J., Wu J.C., Patel D., and Chen D.S. Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles. J Virol 65 (1991) 6630-6636
20. Sureau C., Guerra B., and Lanford R.E. Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion. J Virol 67 (1993) 366-372
21. Barrera A., Guerra B., Notvall L., and Lanford R.E. Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition. J Virol 79 (2005) 9786-9798
22. Gudima S., He Y., Chai N., Bruss V., Urban S., Mason W., et al. Primary human hepatocytes are susceptible to infection by hepatitis delta virus assembled with envelope proteins of woodchuck hepatitis virus. J Virol 82 (2008) 7276-7283
23. Chang J., Nie X., Chang H.E., Han Z., and Taylor J. Transcription of hepatitis delta virus RNA by RNA polymerase II. J Virol 82 (2008) 1118-1127
24. Greco-Stewart V.S., Miron P., Abrahem A., and Pelchat M. The human RNA polymerase II interacts with the terminal stem-loop regions of the hepatitis delta virus RNA genome. Virology 357 (2007) 68-78
25. Yamaguchi Y., Mura T., Chanarat S., Okamoto S., and Handa H. Hepatitis delta antigen binds to the clamp of RNA polymerase II and affects transcriptional fidelity. Genes Cells 12 (2007) 863-875
26. Lazinski D.W., and Taylor J.M. Relating structure to function in the hepatitis delta virus antigen. J Virol 67 (1993) 2672-2680
27. Rozzelle Jr. J.E., Wang J.G., Wagner D.S., Erickson B.W., and Lemon S.M. Self-association of a synthetic peptide from the N-terminus of the hepatitis delta virus protein into an immunoreactive alpha-helical multimer. Proc Natl Acad Sci USA 92 (1995) 382-386
28. Xia Y.P., Yeh C.T., Ou J.H., and Lai M.M. Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex. J Virol 66 (1992) 914-921
29. Casey J.L. RNA editing in hepatitis delta virus. Curr Top Microbiol Immunol 307 (2006) 67-89
30. Yamaguchi Y., Filipovska J., Yano K., Furuya A., Inukai N., Narita T., et al. Stimulation of RNA polymerase II elongation by hepatitis delta antigen. Science 293 (2001) 124-127
31. Huang W.H., Chen C.W., Wu H.L., and Chen P.J. Post-translational modification of delta antigen of hepatitis D virus. Curr Top Microbiol Immunol 307 (2006) 91-112
32. Mu J.J., Wu H.L., Chiang B.L., Chang R.P., Chen D.S., and Chen P.J. Characterization of the phosphorylated forms and the phosphorylated residues of hepatitis delta virus delta antigens. J Virol 73 (1999) 10540-10545
33. Chen Y.S., Huang W.H., Hong S.Y., Tsay Y.G., and Chen P.J. ERK1/2-mediated phosphorylation of small hepatitis delta antigen at serine 177 enhances hepatitis delta virus antigenomic RNA replication. J Virol 82 (2008) 9345-9358
34. Tseng C.H., Jeng K.S., and Lai M.M. Transcription of subgenomic mRNA of hepatitis delta virus requires a modified hepatitis delta antigen that is distinct from antigenomic RNA synthesis. J Virol 82 (2008) 9409-9416
35. Li Y.J., Stallcup M.R., and Lai M.M. Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication. J Virol 78 (2004) 13325-13334
36. Glenn J.S., Watson J.A., Havel C.M., and White J.M. Identification of a prenylation site in delta virus large antigen. Science 256 (1992) 1331-1333
37. Lee C.Z., and Sheu J.C. Histone H1e interacts with small hepatitis delta antigen and affects hepatitis delta virus replication. Virology 375 (2008) 197-204
38. Huang W.H., Chen Y.S., and Chen P.J. Nucleolar targeting of hepatitis delta antigen abolishes its ability to initiate viral antigenomic RNA replication. J Virol 82 (2008) 692-699
39. Huang W.H., Mai R.T., and Lee Y.H. Transcription factor YY1 and its associated acetyltransferases CBP and p300 interact with hepatitis delta antigens and modulate hepatitis delta virus RNA replication. J Virol 82 (2008) 7313-7324
40. O'Malley B., and Lazinski D.W. Roles of carboxyl-terminal and farnesylated residues in the functions of the large hepatitis delta antigen. J Virol 79 (2005) 1142-1153
41. Choi S.H., Jeong S.H., and Hwang S.B. Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: implication of hepatitis delta virus-induced liver fibrosis. Gastroenterology 132 (2007) 343-357
42. Smedile A., Niro M.G., and Rizzetto M. Detection of serum HDV RNA by RT-PCR. In: Hamatake R.K., and Lau J.Y.N. (Eds). NJ Methods in Molecular Medicine, vol. 95: Hepatitis B and D protocols, vol. 1 vol. 95 (2004), Humana Press Inc., Totowa 85-93
43. Le Gal F., Gordien E., Affolabi D., Hanslik T., Alloui C., Dény P., et al. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. J Clin Microbiol 43 (2005) 2363-2369
44. Rizzetto M., Ponzetto A., and Forzani I. Hepatitis Delta Virus as a global health problem. Vaccine 8 (1990) S10-S14
45. Rizzetto M., Verme G., Recchia S., Bonino F., Farci P., Aricò S., et al. Chronic HBsAg hepatitis with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 98 (1983) 437-441
46. Smedile A., Rizzetto M., and Gerin J.L. Advances in Hepatitis D Virus Biology and Disease. In: Boyer J.L., and Ockner R.K. (Eds). Progress in Liver Disease vol. XII (1994), Saunders Company 157-175
47. Hadziyannis S.J., Hatzakis A., Papaioannou C., Anastassakos C., and Vassiliadis E. Endemic hepatitis delta virus infection in a Greek community. Prog Clin Biol Res 234 (1987) 181-202
48. Dény P. Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades?. Curr Top Microbiol Immunol 307 (2006) 151-171
49. Su C.W., Huang Y.H., Huo T.I., Shih H.H., Sheen I.J., Chen S.W., et al. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology 130 (2006) 1625-1635
50. Wu J.C. Functional and clinical significance of hepatitis D virus genotype II infection. Curr Top Microbiol Immunol 307 (2006) 173-186
51. Watanabe H., Nagayama K., Enomoto N., Chinzei R., Yamashiro T., Izumi N., et al. Chronic hepatitis delta virus infection with genotype II b variant is correlated with progressive liver disease. J Gen Virol 84 (2003) 3275-3289
52. Shih H.H., Jeng K.S., Syu W.J., Huang Y.H., Su C.W., Peng W.L., et al. Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis D virus. J Virol 82 (2008) 2250-2264
53. Hadziyannis S.J. Decreasing prevalence of hepatitis D virus infection. J Gastroenterol Hepatol 12 (1997) 745-746
54. Smedile A., Lavarini C., Farci P., Aricò S., Marinucci G., Dentico P., et al. Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. Am J Epidemiol 117 (1983) 223-229
55. Sagnelli E., Stroffolini T., Ascione A., Bonino F., Chiaramonte M., Colombo M., et al. The epidemiology of hepatitis delta infection in Italy. J Hepatol 15 (1992) 211-215
56. Sagnelli E., Stroffolini T., Ascione A., Chiaramonte M., Craxi{dotless}̀ A., Giusti G., et al. Decrease in HDV endemicity in Italy. J Hepatol 26 (1997) 20-24
57. Gaeta G.B., Stroffolini T., Chiaramonte M., Ascione T., Stornaiuolo G., Lobello S., et al. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology 32 (2000) 824-827
58. Navascués C.A., Rodri{dotless}́guez M., Sotorri{dotless}́o N.G., Sala P., Linares A., Suárez A., et al. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol 90 (1995) 1981-1984
59. Huo T.I., Wu J.C., Lin R.Y., Sheng W.Y., Chang F.Y., and Lee S.D. Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol 12 (1997) 747-751
60. Deǧertekin H., Yalçin K., and Yakut M. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies. Turk J Gastroenterol 17 (2006) 25-34
61. Rosina F., Conoscitore P., Cuppone R., Rocca G., Giuliani A., Cozzolongo R., et al. Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology 117 (1999) 161-166
62. Fattovich G., Giustina G., Christensen E., Pantalena M., Zagni I., Realdi G., et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European concerted action on viral hepatitis. Gut 46 (2000) 420-426
63. Ciancio A, Rizzetto M. Clinical patterns, epidemiology and disease burden of hepatitis D virus chronic liver disease. In: Margolis HS, Alter MJ, Liang TJ et al., editors. Proceedings of the 10th International symposium on viral hepatitis and liver disease. Atlanta, GA: International Medical Press, 2002; p. 271-75.
64. Zuberi B.F., Quraishy M.S., Afsar S., Kazi L.A., Memon A.R., Qadeer R., et al. Frequency and comparative analysis of hepatitis D in patients seeking treatment for hepatitis B. J Coll Physicians Surg Pak 16 (2006) 581-584
65. Acharya S.K., Madan K., Dattagupta S., and Panda S.K. Viral hepatitis in India. Natl Med J India 19 (2006) 203-217
66. Tsatsralt-Od B., Takahashi M., Endo K., Buyankhuu O., Baatarkhuu O., Nishizawa T., et al. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia. J Med Virol 78 (2006) 542-550
67. Roshandel G., Semnani S., Abdolahi N., Keshtkar A.A., Besharat S., Joshaghani H., et al. Prevalence of hepatitis D virus infection in HBsAg positive subjects in Iran. J Biol Sci 10 (2007) 1751-1754
68. Gholamreza R., Shahryar S., Abbasali K., Hamidreza J., Abdolvahab M., Khodaberdi K., et al. Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population. Indian J Med Sci 61 (2007) 263-268
69. Nguyen V.T., McLaws M.L., and Dore G.J. Highly endemic hepatitis B infection in rural Vietnam. J Gastroenterol Hepatol 22 (2007) 2093-2100
70. Khan A., Kurbanov F., Tanaka Y., Elkady A., Sugiyama M., Dustov A., et al. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. J Med Virol 80 (2008) 268-276
71. Djebbi A, Rebai WK, Bahri O, Hogga N, Sadraoui A, Triki H. Serological markers, viral RNA and genotype of hepatitis delta virus in HBs antigen positive Tunisian patients. Pathol Biol (Paris), in press.
72. Cross T.J.S., Rizzi P., Horner M., Jolly A., Hussain M.J., Smith H.M., et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 80 (2008) 277-282
73. Wedemeyer H., Heidrich B., and Manns M.P. Hepatitis D virus infection-not a vanishing disease in Europe!. Hepatology 45 (2007) 1331-1332
74. Le Gal F., Castelneau C., Gault E., al Hawajri N., Gordien E., Marcelline P., et al. Hepatitis D virus infection. Not a vanishing disease in Europe!. Hepatology 45 (2007) 1332-1333
75. Gaeta G.B., Stroffolini T., Smedile A., Niro G., and Mele A. Hepatitis delta in Europe: vanishing or refreshing?. Hepatology 46 (2007) 1312-1313
76. Erhardt A., Knuth R., Sagir A., Kirschberg O., Heintges T., and Häussinger D. Socioepidemiological data on hepatitis delta in a German university clinic-increase in patients from Eastern Europe and the former Soviet Union. Z Gastroenterol 41 (2003) 523-526
77. Niro G.A., Rosina F., and Rizzetto M. Treatment of hepatitis D. J Viral Hepat 12 (2005) 2-9
78. Farci P. Delta hepatitis: an update. J Hepatol 39 (2003) S212-S219
79. Yurdaydin C., Bozkaya H., Karaaslan H., Onder F.O., Erkan O.E., Yalçin K., et al. A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis. J Viral Hepat 14 (2007) 812-816
80. Castelnau C., Le Gal F., Ripault M.P., Gordien E., Martinot-Peignoux M., Boyer N., et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 44 (2006) 728-735
81. Erhardt A., Gerlich W., Starke C., Wend U., Donner A., Sagir A., et al. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Int 26 (2006) 805-810
82. Niro G.A., Ciancio A., Gaeta G.B., Smedile A., Marrone A., Olivero A., et al. Pegylated interferon alpha-2b as monotherapy or in combination with Ribavirin in chronic hepatitis delta. Hepatology 44 (2006) 713-720
83. Niro G.A., Gravinese E., Martini E., Garrubba M., Facciorusso D., Conoscitore P., et al. Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies. Liver 21 (2001) 254-259
84. Pugnale P, Pazienza V, Guilloux K, Negro F. Hepatitis delta virus inhibits alpha interferon signaling. Hepatology 2008;49:398-406.
85. Yurdaydin C., Bozkaya H., Onder F.O., Sentürk H., Karaaslan H., Akdoǧan M., et al. Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon. J Viral Hepat 15 (2008) 314-321
86. Shih H.H., Jeng K.S., Syu W.J., Huang Y.H., Su C.W., Peng W.L., et al. Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus. J Virol 82 (2008) 2250-2264
87. Manesis E.K., Schina M., Le Gal F., Agelopoulou O., Papaioannou C., Kalligeros C., et al. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring. Antivir Ther 12 (2007) 381-388
88. Jenna S., and Sureau C. Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus. Virology 251 (1998) 176-186
89. Komla-Soukha I., and Sureau C. A tryptophan-rich motif in the carboxyl terminus of the small envelope protein of hepatitis B virus is central to the assembly of hepatitis delta virus particles. J Virol 80 (2006) 4648-4655
90. Abou-Jaoudé G., and Sureau C. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange. J Virol 81 (2007) 13057-13066
91. Vietheer P.T., Netter H.J., Sozzi T., and Bartholomeusz A. Failure of the lamivudine-resistant rtM204I hepatitis B virus mutants to efficiently support hepatitis delta virus secretion. J Virol 79 (2005) 6570-6573
92. Glenn J.S. Prenylation of HDAg and antiviral drug development. Curr Top Microbiol Immunol 307 (2006) 133-149
93. Bordier B.B., Ohkanda J., Liu P., Lee S.Y., Salazar F.H., Marion P.L., et al. In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. J Clin Invest 112 (2003) 407-414
94. Asif-Ullah M., Lévesque M., Robichaud G., and Perreault J.P. Development of ribozyme-based gene-inactivations; the example of the hepatitis delta virus ribozyme. Curr Gene Ther 7 (2007) 205-216